Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era
- PMID: 21199857
- PMCID: PMC4865884
- DOI: 10.1542/peds.2010-0962
Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era
Abstract
Objective: To describe the effect of the mature 1-dose varicella vaccination program on varicella morbidity, we analyzed 2 national databases for varicella-related hospitalizations in the United States since implementation of the varicella vaccination program in 1995.
Patients and methods: Data from the National Hospital Discharge Survey and Nationwide Inpatient Sample were analyzed to describe trends in varicella-related hospitalizations during the 1-dose vaccination era (2000-2006) compared with those in the prevaccination era (1988-1995). Varicella-related hospitalizations were defined by using International Classification of Diseases, Ninth Revision codes. Results were extrapolated to represent national estimates.
Results: Using National Hospital Discharge Survey data, 24,488 varicella-related hospitalizations were estimated to occur in the United States during the 1-dose vaccination era. The varicella-related hospitalization rate was 0.12 per 10,000 population during the 1-dose vaccination era versus 0.42 per 10,000 population in the prevaccination era (P < .01). During the 1-dose vaccination era, the estimated annual average number of varicella-related hospitalizations was significantly lower and decreased by ≥ 65% in all age groups compared with those in the prevaccination era (P < .001 in all age groups). The varicella-related hospitalization rate during the 1-dose vaccination era estimated from the Nationwide Inpatient Sample was 0.09 per 10,000 population.
Conclusions: Varicella-related hospitalization numbers and rates declined significantly during the 1-dose varicella vaccination era. Assuming declines in varicella-related hospitalizations are due, mainly, to the routine childhood varicella vaccination program, these data suggest that varicella vaccination prevented ∼ 50,000 varicella-related hospitalizations in the United States from 2000 to 2006.
Figures



Similar articles
-
Varicella-related hospitalizations in the vaccine era.Pediatr Infect Dis J. 2002 Oct;21(10):927-31. doi: 10.1097/00006454-200210000-00008. Pediatr Infect Dis J. 2002. PMID: 12394814
-
Hospitalizations for varicella in the United States, 1988 to 1999.Pediatr Infect Dis J. 2002 Oct;21(10):931-5. doi: 10.1097/00006454-200210000-00009. Pediatr Infect Dis J. 2002. PMID: 12394815
-
Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994-2012.J Pediatric Infect Dis Soc. 2016 Dec;5(4):395-402. doi: 10.1093/jpids/piv044. Epub 2015 Aug 12. J Pediatric Infect Dis Soc. 2016. PMID: 26407276 Free PMC article.
-
Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.Expert Rev Vaccines. 2017 Mar;16(3):229-234. doi: 10.1080/14760584.2017.1247700. Epub 2016 Oct 27. Expert Rev Vaccines. 2017. PMID: 27786560 Review.
-
The effect of active immunization on varicella-related hospitalizations in Israel.Hum Vaccin. 2009 Mar;5(3):136-40. doi: 10.4161/hv.5.3.6811. Epub 2009 Mar 18. Hum Vaccin. 2009. PMID: 19246993 Review.
Cited by
-
Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.Bull World Health Organ. 2014 Aug 1;92(8):593-604. doi: 10.2471/BLT.13.132142. Epub 2014 Jun 13. Bull World Health Organ. 2014. PMID: 25177074 Free PMC article.
-
Severe skin complications of varicella in previously healthy children in Iran: emerging concern.BMC Infect Dis. 2025 Mar 24;25(1):402. doi: 10.1186/s12879-025-10794-w. BMC Infect Dis. 2025. PMID: 40128649 Free PMC article.
-
Neurovirulence of varicella and the live attenuated varicella vaccine virus.Semin Pediatr Neurol. 2012 Sep;19(3):124-9. doi: 10.1016/j.spen.2012.02.006. Semin Pediatr Neurol. 2012. PMID: 22889542 Free PMC article. Review.
-
Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.Hum Vaccin Immunother. 2015;11(3):662-8. doi: 10.1080/21645515.2015.1008880. Hum Vaccin Immunother. 2015. PMID: 25714052 Free PMC article.
-
Varicella and varicella vaccination in South Korea.Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26. Clin Vaccine Immunol. 2014. PMID: 24671555 Free PMC article.
References
-
- Marin M, Güris D, Chaves SS, Schmid S, Seward JF Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56(RR–4):1–40. - PubMed
-
- Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114(3):786–792. - PubMed
-
- Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352(5):450–458. - PubMed
-
- Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites: United States, 1995–2005. J Infect Dis. 2008;197(suppl 2):S71–S75. - PubMed
-
- Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797–802. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical